Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01500304 · ClinicalTrials.gov registry record · NA
Minimally Invasive Groin Dissection for Melanoma
A NA study of Melanoma, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 88
- Enrollment target
- 11
- Study locations
NCT01500304: Completed NA study of Melanoma, sponsored by Mayo Clinic.
NCT01500304 is a NA study of Melanoma that has completed, run by Mayo Clinic. The registered enrollment target is 88 participants, below the 706-participant average among 266 other Melanoma trials with a reported enrollment target (88% lower). The trial reports 11 study locations across 9 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01500304, a NA study of Melanoma, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 88 participants
- Enrollment target
- 11
- Study locations
Study Summary
The purpose of this this study is to determine if a structured educational training program is successful in teaching surgeons a new operative technique. It will then be determined if this new operative technique is safe.
Primary Outcome
The proficiency score is a function of the lymph nodes pathologically identified, the amount of blood transfused and the operative time. The range is 0 to 3, with higher proficiency in performing the procedure being 3.
Conditions Studied
Interventions
- PROCEDURE Minimally invasive inguinal lymph node dissection
Study Locations (11)
Florida
- Mayo Clinic in Florida - Jacksonville
- H. Lee Moffitt Cancer Center and Research Institute - Tampa
Ohio
- MetroHealth Medical Center - Cleveland
- The Ohio State University Medical Center - Columbus
Arizona
- Mayo Clinic in Arizona - Scottsdale
California
- John Wayne Cancer Institute - Santa Monica
Illinois
- Northwestern Memorial Hospital - Chicago
New York
- Memorial Sloan Kettering Cancer Center - New York
North Carolina
- Duke University Medical Center - Durham
Pennsylvania
- Fox Chase Cancer Center - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 88 participants |
| Start Date | 2012-06 |
| Est. Completion | 2015-12 |
| Phase | NA |
What the finished NCT01500304 record still lists
NCT01500304 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 88 participants, a relatively small participant target, below the 706-participant average among 266 other Melanoma trials with a reported enrollment target (88% lower).
The record links to 1 condition, with Melanoma appearing as the primary indexed condition, and to 1 intervention - of which Minimally invasive inguinal lymph node dissection is the first listed.
NCT01500304 lists 11 locations in 9 states (Florida, Ohio, Arizona).
Frequently Asked Questions
What is clinical trial NCT01500304 about?
NCT01500304 is a clinical study titled "Minimally Invasive Groin Dissection for Melanoma". The purpose of this this study is to determine if a structured educational training program is successful in teaching surgeons a new operative technique. It will then be determined if this new operative technique is safe.
What is the current status of trial NCT01500304?
This trial is currently completed. It is a NA study. The enrollment target is 88 participants. The study started on 2012-06. Estimated completion is 2015-12.
What conditions does trial NCT01500304 study?
This clinical trial studies the following conditions: Melanoma.
What interventions are being tested in trial NCT01500304?
The interventions under investigation include: Minimally invasive inguinal lymph node dissection (PROCEDURE).
Who is sponsoring clinical trial NCT01500304?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01500304 being conducted?
This trial has 11 study locations across Arizona, California, Florida, Illinois, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Melanoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01500304's enrollment target sits among peer trials
88 122nd of 266 higher than 145 of 266 other Melanoma trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Melanoma trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Lymphovenous Bypass Procedure Before Underarm Lymph Node Surgery in Preventing Lymphedema in Patients With Inflammatory or Locally Advanced Non-inflammatory Breast Cancer or Melanoma
RECRUITING · NA
-
Promoting Immunotherapy Efficacy With Low-Dose Liver RT
RECRUITING · NA
-
A Study Evaluating the Integrative Medicine at Home (IM@HOME) Program in People With Cancer
RECRUITING · NA
-
MySmartSkin Online Skin Self-exam Intervention for Melanoma Survivors
RECRUITING · NA
-
Studying Quality of Life Inclusive of Mental Health and Cognitive Behavioral Therapy for Cancer Distress for the Improvement of Quality of Life in Stage III-IV Melanoma Patients
RECRUITING · NA
-
High Dose-Rate Brachytherapy for the Treatment of Both Primary and Secondary Unresectable Liver Malignancies
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03843463 · 88 participants · Phase 2
Escitalopram and Language Intervention for Subacute Aphasia
- NCT04066348 · 88 participants · Phase 2
TNF-α Treatment of Blast-Induced Tinnitus
- NCT04331704 · 88 participants · Phase 4
ANCHORS Alcohol & Sexual Health Study: UH3 Project
- NCT04536103 · 88 participants
Multi-Vendor Multi-Site Novel Accelerated MRI Relaxometry
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia